BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
0.758
+0.155 (25.88%)
Nov 21, 2024, 12:59 PM EST - Market open
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of $21.75 million as of November 21, 2024. Its market cap has decreased by -67.73% in one year.
Market Cap
21.75M
Enterprise Value
20.60M
1-Year Change
-67.73%
Ranking
Category
Stock Price
$0.76
Market Cap Chart
Since February 24, 2021, BriaCell Therapeutics's market cap has decreased from $26.00M to $21.75M, a decrease of -16.34%. That is a compound annual growth rate of -4.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 21.80M | -76.68% |
| Dec 29, 2023 | 93.50M | 37.91% |
| Dec 30, 2022 | 67.80M | -46.74% |
| Dec 31, 2021 | 127.30M | 389.62% |
| Feb 24, 2021 | 26.00M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cocrystal Pharma | 20.96M |
| Spectral AI | 20.92M |
| bioAffinity Technologies | 20.73M |
| Pieris Pharmaceuticals | 20.64M |
| VSee Health | 20.59M |
| Movano | 20.45M |
| iBio, Inc. | 20.40M |
| NeuroOne Medical Technologies | 20.37M |